| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | regulation of flagellated sperm motility | 1.42e-05 | 28 | 35 | 3 | GO:1901317 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-activating G protein-coupled receptor signaling pathway | 1.67e-05 | 191 | 35 | 5 | GO:0007189 | |
| GeneOntologyBiologicalProcess | sensory perception of chemical stimulus | 3.13e-05 | 547 | 35 | 7 | GO:0007606 | |
| GeneOntologyBiologicalProcess | regulation of cilium movement involved in cell motility | 3.34e-05 | 37 | 35 | 3 | GO:0060295 | |
| GeneOntologyBiologicalProcess | regulation of cilium-dependent cell motility | 3.34e-05 | 37 | 35 | 3 | GO:1902019 | |
| GeneOntologyBiologicalProcess | positive regulation of response to food | 5.84e-05 | 7 | 35 | 2 | GO:0032097 | |
| GeneOntologyBiologicalProcess | positive regulation of appetite | 5.84e-05 | 7 | 35 | 2 | GO:0032100 | |
| GeneOntologyBiologicalProcess | positive regulation of response to nutrient levels | 7.78e-05 | 8 | 35 | 2 | GO:0032109 | |
| GeneOntologyBiologicalProcess | regulation of cilium movement | 7.82e-05 | 49 | 35 | 3 | GO:0003352 | |
| GeneOntologyBiologicalProcess | adenylate cyclase-modulating G protein-coupled receptor signaling pathway | 1.14e-04 | 286 | 35 | 5 | GO:0007188 | |
| GeneOntologyBiologicalProcess | sensory perception of smell | 1.18e-04 | 465 | 35 | 6 | GO:0007608 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based movement | 2.08e-04 | 68 | 35 | 3 | GO:0060632 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 2.13e-04 | 327 | 35 | 5 | GO:0048738 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 2.88e-04 | 349 | 35 | 5 | GO:0014706 | |
| GeneOntologyBiologicalProcess | ventricular cardiac muscle tissue development | 2.89e-04 | 76 | 35 | 3 | GO:0003229 | |
| GeneOntologyBiologicalProcess | sensory perception | 3.48e-04 | 1072 | 35 | 8 | GO:0007600 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium-dependent cell motility | 4.21e-04 | 18 | 35 | 2 | GO:2000155 | |
| GeneOntologyBiologicalProcess | positive regulation of flagellated sperm motility | 4.21e-04 | 18 | 35 | 2 | GO:1902093 | |
| GeneOntologyBiologicalProcess | positive regulation of cilium movement | 4.70e-04 | 19 | 35 | 2 | GO:0003353 | |
| GeneOntologyBiologicalProcess | cellular response to leukemia inhibitory factor | 7.05e-04 | 103 | 35 | 3 | GO:1990830 | |
| GeneOntologyBiologicalProcess | response to leukemia inhibitory factor | 7.45e-04 | 105 | 35 | 3 | GO:1990823 | |
| Domain | TSPN | 8.42e-04 | 23 | 35 | 2 | SM00210 | |
| Domain | P-loop_NTPase | 4.52e-03 | 848 | 35 | 6 | IPR027417 | |
| Domain | Laminin_G | 5.28e-03 | 58 | 35 | 2 | IPR001791 | |
| Domain | ConA-like_dom | 7.90e-03 | 219 | 35 | 3 | IPR013320 | |
| Domain | - | 1.21e-02 | 746 | 35 | 5 | 3.40.50.300 | |
| Pubmed | The Asprosin-OLFR734 hormonal signaling axis modulates male fertility. | 3.12e-06 | 3 | 36 | 2 | 31798959 | |
| Pubmed | 3.12e-06 | 3 | 36 | 2 | 32337066 | ||
| Pubmed | Whirlin complexes with p55 at the stereocilia tip during hair cell development. | 6.24e-06 | 4 | 36 | 2 | 16829577 | |
| Pubmed | OLFR734 Mediates Glucose Metabolism as a Receptor of Asprosin. | 6.24e-06 | 4 | 36 | 2 | 31230984 | |
| Pubmed | Collagen XIV is important for growth and structural integrity of the myocardium. | 6.83e-05 | 12 | 36 | 2 | 22906538 | |
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 31669249 | ||
| Pubmed | 1.24e-04 | 16 | 36 | 2 | 29764992 | ||
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 1.73e-04 | 104 | 36 | 3 | 31240132 | |
| Pubmed | Identification of genes concordantly expressed with Atoh1 during inner ear development. | 1.76e-04 | 19 | 36 | 2 | 21519551 | |
| Pubmed | The human (PEDB) and mouse (mPEDB) Prostate Expression Databases. | 1.83e-04 | 106 | 36 | 3 | 11752298 | |
| Pubmed | 2.16e-04 | 21 | 36 | 2 | 37422473 | ||
| Pubmed | 3.01e-04 | 1285 | 36 | 7 | 35914814 | ||
| Pubmed | 3.08e-04 | 25 | 36 | 2 | 38877142 | ||
| Pubmed | Lysine acetylation targets protein complexes and co-regulates major cellular functions. | 7.15e-04 | 38 | 36 | 2 | 19608861 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 7.40e-04 | 171 | 36 | 3 | 20201926 | |
| Pubmed | 7.93e-04 | 40 | 36 | 2 | 19864314 | ||
| GeneFamily | Olfactory receptors, family 4 | 1.93e-02 | 129 | 30 | 2 | 151 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 7.47e-06 | 177 | 33 | 5 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 9.38e-06 | 86 | 33 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_100 | 1.03e-05 | 88 | 33 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_100 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_200 | 2.78e-05 | 38 | 33 | 3 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_500 | 3.28e-05 | 404 | 33 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_500 | 4.76e-05 | 432 | 33 | 6 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_500 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_200 | 6.93e-05 | 143 | 33 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_200 | 1.02e-04 | 158 | 33 | 4 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_100 | 1.05e-04 | 10 | 33 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_200 | 1.35e-04 | 170 | 33 | 4 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_200 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_200 | 1.38e-04 | 171 | 33 | 4 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | 1.48e-04 | 768 | 33 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 1.67e-04 | 69 | 33 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_100 | 1.81e-04 | 13 | 33 | 2 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k1_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_100 | 1.81e-04 | 13 | 33 | 2 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.12e-04 | 191 | 33 | 4 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | 2.33e-04 | 827 | 33 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_100 | 2.40e-04 | 78 | 33 | 3 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 2.51e-04 | 837 | 33 | 7 | gudmap_dev gonad_e11.5_M_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.29e-04 | 230 | 33 | 4 | gudmap_developingGonad_e18.5_ovary_1000_k5 | |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.29e-04 | 230 | 33 | 4 | ratio_DE_vs_SC_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.50e-04 | 233 | 33 | 4 | gudmap_developingGonad_e12.5_ovary_k5_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_500 | 4.70e-04 | 98 | 33 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | 5.11e-04 | 433 | 33 | 5 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | 5.47e-04 | 1259 | 33 | 8 | facebase_RNAseq_e9.5_MandArch_2500_K3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | 5.55e-04 | 441 | 33 | 5 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 5.60e-04 | 104 | 33 | 3 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#2_top-relative-expression-ranked_200 | 5.81e-04 | 23 | 33 | 2 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.96e-04 | 251 | 33 | 4 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k2_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#4_top-relative-expression-ranked_100 | 7.44e-04 | 26 | 33 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k4_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_200 | 7.44e-04 | 26 | 33 | 2 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k2_200 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000 | 8.69e-04 | 740 | 33 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 1.06e-03 | 31 | 33 | 2 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_k3_200 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | 1.11e-03 | 776 | 33 | 6 | gudmap_developingGonad_e14.5_ ovary_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | 1.13e-03 | 778 | 33 | 6 | gudmap_developingGonad_e18.5_ovary_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000 | 1.16e-03 | 783 | 33 | 6 | gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100 | 1.20e-03 | 33 | 33 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | 1.23e-03 | 791 | 33 | 6 | gudmap_dev gonad_e11.5_F_SupCellPrec_Sry_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | 1.24e-03 | 793 | 33 | 6 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_200 | 1.24e-03 | 137 | 33 | 3 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_200 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_200 | 1.27e-03 | 138 | 33 | 3 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.27e-03 | 138 | 33 | 3 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ bladder_emap-30872_k-means-cluster#3_top-relative-expression-ranked_100 | 1.27e-03 | 34 | 33 | 2 | gudmap_developingLowerUrinaryTract_e14.5_ bladder_100_k3 | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000 | 1.28e-03 | 797 | 33 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000 | |
| CoexpressionAtlas | JC_iEC_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.32e-03 | 311 | 33 | 4 | JC_iEC_2500_K3 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l44-58|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.10e-07 | 183 | 35 | 5 | dc9602bed3136db91faeffef177006246dc92743 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 161 | 35 | 4 | f1d3287d9cb4e0eec99b3509f5dc4b87ae8c8cc9 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.59e-06 | 161 | 35 | 4 | 110cc7122e3c9f105a11d811d77c8a8852b9de6c | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.26e-05 | 183 | 35 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.43e-05 | 189 | 35 | 4 | 0e8d1be3c406d1a393e18faccfe89116a8f82bcf | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8|blood / Manually curated celltypes from each tissue | 1.46e-05 | 190 | 35 | 4 | 5dca8654964c41580fa3b094579fe7cb296d406f | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.52e-05 | 192 | 35 | 4 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.55e-05 | 193 | 35 | 4 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 1.55e-05 | 193 | 35 | 4 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 193 | 35 | 4 | f42a0f02ed00fe1bb833ff0a0640d9131bca89bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 193 | 35 | 4 | 42df7ed37d11fb542b4d1d714b6f87ae8e1396a6 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.58e-05 | 194 | 35 | 4 | 9588a9b4baebbae08e13d201d4b9dfcf0e6521fb | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 1.58e-05 | 194 | 35 | 4 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.58e-05 | 194 | 35 | 4 | e577d9e88390b36b5a09b97fe1026089892275a3 | |
| ToppCell | T_cells-GZMK+_T_cells|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.61e-05 | 195 | 35 | 4 | 003ea7ddec6c1c98d2f6470bb51ebd97450eb936 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.65e-05 | 196 | 35 | 4 | c06caba0c91b8ee66f42bc43ec75eb2475f07056 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-05 | 196 | 35 | 4 | 093fb240e72911dfd360aa6edf8ed2d611c78a1e | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.68e-05 | 197 | 35 | 4 | b5b333e98753946793ceb45e2d85c25ef53568b4 | |
| ToppCell | normal-na-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.68e-05 | 197 | 35 | 4 | 4cec48e202f4583c9328d4b722c49ed3471ec173 | |
| ToppCell | mild-Lymphocytic-NK_cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.71e-05 | 198 | 35 | 4 | 1d20fc9948965de52a98f758035edfdd12cafc5f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.71e-05 | 198 | 35 | 4 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | severe-CD8+_Tem|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.78e-05 | 200 | 35 | 4 | 6aa77955017d073a96324e4db6b9950a2ec46cf8 | |
| ToppCell | severe-gd_T|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.78e-05 | 200 | 35 | 4 | 2253d74049cc49c92e897ff4aa298d913daeb739 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.35e-04 | 127 | 35 | 3 | 9bc55cb9f4bddb274930784d12a83b9dceb35cb7 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.58e-04 | 134 | 35 | 3 | 3b67c02b430b6d58467f36e606c478d3eea0063f | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-T_CD4/CD8|blood / Manually curated celltypes from each tissue | 1.61e-04 | 135 | 35 | 3 | ae2d3a42e567b5bade304c0caa497eb725be3565 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-04 | 136 | 35 | 3 | a2063abe2d7c3277bfbe1514c8c66363cf04b248 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Meg-Ery-Mes-Epi-like-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-04 | 137 | 35 | 3 | 8e2fa2ef8becace96a68bb85c002329110902fbb | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|blood / Manually curated celltypes from each tissue | 1.72e-04 | 138 | 35 | 3 | 9f8389a34c400a6b2b9bf6cef3a71499cc945e35 | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 2.11e-04 | 148 | 35 | 3 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | Influenza_Severe-CD4+_T_naive|World / Disease group and Cell class | 2.16e-04 | 149 | 35 | 3 | ce6552063510aa3e0b9d6e5b531eea67410e7056 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-04 | 156 | 35 | 3 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | Influenza_Severe-CD4+_T_naive|Influenza_Severe / Disease group and Cell class | 2.51e-04 | 157 | 35 | 3 | 287bdc4e455cd0160261a93d13538e0def49fcd4 | |
| ToppCell | severe_influenza-CD4+_T_naive|World / disease group, cell group and cell class (v2) | 2.56e-04 | 158 | 35 | 3 | 8ab3d8a9b7a1daa890d76dde1d6182af40b70021 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.61e-04 | 159 | 35 | 3 | 235ed12053b337aca5abc2ce8727332b4ae3f8ae | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.66e-04 | 160 | 35 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | COVID-CD8-CD8_2|COVID / Condition, Cell_class and T cell subcluster | 2.71e-04 | 161 | 35 | 3 | 307dcc17475413cd9eb70c27bc447f938ee5723d | |
| ToppCell | URO-Lymphocyte-T_NK-CD4_CTL|URO / Disease, Lineage and Cell Type | 2.76e-04 | 162 | 35 | 3 | 1afeeb17e263cf625a4f285203cf82f973735193 | |
| ToppCell | Basal_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.86e-04 | 164 | 35 | 3 | b15a26130a1ea1b370b6e3be21f02a0d6aaf6b3c | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.86e-04 | 164 | 35 | 3 | 24fdea5113d92b96f56b06dd2449910a3c785e69 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-Klrb1a/b/c(-)_NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.91e-04 | 165 | 35 | 3 | eeb58d4db64ad37dc6b441eab22b05c24862e1a9 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Erythro-Mega|bone_marrow / Manually curated celltypes from each tissue | 2.96e-04 | 166 | 35 | 3 | a853005a5587d42daecdf2e23a93109919021a4f | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 3.07e-04 | 168 | 35 | 3 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 168 | 35 | 3 | 4b2d29a7843bf45922038c093ca7ec0600756adc | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.07e-04 | 168 | 35 | 3 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | metastatic_Lymph_Node-T/NK_cells-Exhausted_Tfh|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.12e-04 | 169 | 35 | 3 | ad9054ee09033b648a76baf1b2ec4a6ab1394bde | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.23e-04 | 171 | 35 | 3 | 5d31fc9b60329d4ae3c77e4ca679359d9314397d | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 3.23e-04 | 171 | 35 | 3 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-T_cells-SELL+_CD8_T|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-04 | 172 | 35 | 3 | 10090b4b40f0f6f07a514e86811cadeecdf21670 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 173 | 35 | 3 | f612d4ea9ab8dcde475f4118bca3e49be786e7fa | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_acinar_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-04 | 173 | 35 | 3 | c62e3ffed55bbb00dcaef6da0aab8446f3f55085 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 3.34e-04 | 173 | 35 | 3 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.40e-04 | 174 | 35 | 3 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.40e-04 | 174 | 35 | 3 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 175 | 35 | 3 | 3f1b2e23fec953148fb0711e523c463adb07dca4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.51e-04 | 176 | 35 | 3 | 5914e7635474e7cf24d446bdb1423bc0807ee9c6 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-gdT|Int-URO / Disease, Lineage and Cell Type | 3.51e-04 | 176 | 35 | 3 | 15016a73c953d8d3e7c32a05ead5e7261f9914ca | |
| ToppCell | Control-Lymphocyte-T_NK-CD8_TCM|Control / Disease, Lineage and Cell Type | 3.51e-04 | 176 | 35 | 3 | 1a7948eb86ee1da607db4d0576312b2859d94523 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.51e-04 | 176 | 35 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.57e-04 | 177 | 35 | 3 | 64b8f665fdaf975558af2ad7d9b54d206de8350c | |
| ToppCell | 10x3'2.3-week_14-16-Lymphocytic_T-T_NK-CD8_T_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.69e-04 | 179 | 35 | 3 | 4e9e0deabf9b09ffcf30fed6d5eae72ce0ef2f1f | |
| ToppCell | facs-Pancreas-Exocrine-18m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-04 | 179 | 35 | 3 | bbfbfb32773346080127055b5aafa36bbf7d0942 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.75e-04 | 180 | 35 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 3.75e-04 | 180 | 35 | 3 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 3.81e-04 | 181 | 35 | 3 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8-Trm/em_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.87e-04 | 182 | 35 | 3 | f857b32de19240a8aca1685f7a78b4e53b04875c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.87e-04 | 182 | 35 | 3 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.94e-04 | 183 | 35 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 3.94e-04 | 183 | 35 | 3 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | COVID-19_Mild-gd_T|COVID-19_Mild / Disease condition and Cell class | 3.94e-04 | 183 | 35 | 3 | f593a89b0aa8fffdfa403769916facfd30358521 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 3.94e-04 | 183 | 35 | 3 | 79defd22b3194dad16db55b9bdd220c09c1e6b90 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.00e-04 | 184 | 35 | 3 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Macula_Densa_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 184 | 35 | 3 | 8fd8bd3d28d0ee6f0ef1f14e354d8eaf63a8081b | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 4.00e-04 | 184 | 35 | 3 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 184 | 35 | 3 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMH+-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.06e-04 | 185 | 35 | 3 | 097d628f92e13250c15b550f2fd1f4225fc07558 | |
| ToppCell | normal-na-Lymphocytic_NK-NK_dim-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 4.06e-04 | 185 | 35 | 3 | b1a8a8c4d0fc7605eabc17dcb6bd9e8ab4fd578c | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l20-1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.06e-04 | 185 | 35 | 3 | d5f5866924648a3c14e2596218fd548a31777aa3 | |
| ToppCell | Mild_COVID-19-Epithelial-AT1/AT2|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.06e-04 | 185 | 35 | 3 | c55fdba1e3818ec0404d7ab473bf18dd25f2bb0a | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.06e-04 | 185 | 35 | 3 | 2d95713deaa05fb3372f4337ef156027e4d8ec8a | |
| ToppCell | Mild-Lymphoid-T-NK|Mild / Condition, Lineage, Cell class and cell subclass | 4.13e-04 | 186 | 35 | 3 | ed37a2df547661d22c1ed0b30cb1c19e489d9d0a | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-mature_NK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.13e-04 | 186 | 35 | 3 | 165d02be3b3eaeb8784a2b0b2020928b21a19bc7 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.13e-04 | 186 | 35 | 3 | f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.13e-04 | 186 | 35 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | mild_COVID-19-CD4+_CTL|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.19e-04 | 187 | 35 | 3 | 49196d07e4716c87d33229a4569bdb6b4613b3eb | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_dim-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.19e-04 | 187 | 35 | 3 | 0bca79cea4886b66350c56c61859bd71e1e7a85c | |
| ToppCell | IPF-Stromal-SMC|World / Disease state, Lineage and Cell class | 4.26e-04 | 188 | 35 | 3 | b66264e8f8d536ed2beec31e6746c687718f239b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD8-Trm/em_CD8|blood / Manually curated celltypes from each tissue | 4.26e-04 | 188 | 35 | 3 | 21730497f95dc271e4cdfaaf1da8b9ac6eec2ded | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-04 | 188 | 35 | 3 | 63a4b25a0a6e05f80f1a6dd91b817f3cf49e6b68 | |
| ToppCell | -Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-04 | 188 | 35 | 3 | 6468fa95ad0395395301115286f2d8c0df5d3882 | |
| ToppCell | -Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-04 | 188 | 35 | 3 | 7a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 4.26e-04 | 188 | 35 | 3 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | -Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.26e-04 | 188 | 35 | 3 | 9cb718bfe1358c6fd842f096e228eb0abb9aefc6 | |
| ToppCell | IPF-Stromal-SMC|IPF / Disease state, Lineage and Cell class | 4.26e-04 | 188 | 35 | 3 | e98b24c0de41285f01f7ac194ff0a1b59fd5c333 | |
| ToppCell | 3'_v3-GI_small-bowel|World / Manually curated celltypes from each tissue | 4.26e-04 | 188 | 35 | 3 | 822c6abaf7bcd6721269bdbd1f2b286ccf0aec1a | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 4.26e-04 | 188 | 35 | 3 | b070a0667f1ee9b825b267b6c389b7c42fc436f9 | |
| ToppCell | COPD-Myeloid-cMonocyte|COPD / Disease state, Lineage and Cell class | 4.33e-04 | 189 | 35 | 3 | d29f3a0bd23e6eb46389e6eb7ef21851c7b57545 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-04 | 189 | 35 | 3 | a75226616340045b581d08429d2e123e041dee55 | |
| ToppCell | COPD-Myeloid-cMonocyte|Myeloid / Disease state, Lineage and Cell class | 4.33e-04 | 189 | 35 | 3 | 6294691231c7d38707323cf31578a107d3b2c622 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-04 | 189 | 35 | 3 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| Drug | lometrexol | 7.48e-06 | 25 | 35 | 3 | CID000001773 | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; PC3; HT_HG-U133A | 1.10e-05 | 193 | 35 | 5 | 6643_UP | |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A | 1.10e-05 | 193 | 35 | 5 | 455_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; PC3; HT_HG-U133A | 1.13e-05 | 194 | 35 | 5 | 6741_UP | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; PC3; HT_HG-U133A | 1.18e-05 | 196 | 35 | 5 | 3696_UP | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.24e-05 | 198 | 35 | 5 | 4358_UP | |
| Drug | indomethacin, USP; Down 200; 100uM; PC3; HG-U133A | 1.24e-05 | 198 | 35 | 5 | 452_DN | |
| Drug | Etofylline [519-37-9]; Up 200; 17.8uM; PC3; HT_HG-U133A | 1.27e-05 | 199 | 35 | 5 | 5048_UP | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Up 200; 2.6uM; HL60; HT_HG-U133A | 1.27e-05 | 199 | 35 | 5 | 2498_UP | |
| Drug | CH3S | 6.98e-05 | 52 | 35 | 3 | CID000123247 | |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.97e-04 | 189 | 35 | 4 | 4400_DN | |
| Drug | diacetylene | 2.07e-04 | 14 | 35 | 2 | CID000009997 | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.13e-04 | 193 | 35 | 4 | 3684_UP | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 2299_UP | |
| Drug | Atovaquone [95233-18-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.18e-04 | 194 | 35 | 4 | 4786_UP | |
| Drug | Glipizide [29094-61-9]; Up 200; 9uM; MCF7; HT_HG-U133A | 2.22e-04 | 195 | 35 | 4 | 4991_UP | |
| Drug | Lidocaone hydrochloride [73-78-9]; Up 200; 14.8uM; PC3; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 4596_UP | |
| Drug | Cefixime [79350-37-1]; Up 200; 8.8uM; PC3; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 4567_UP | |
| Drug | trichostatin A; Down 200; 0.1uM; HL60; HG-U133A | 2.26e-04 | 196 | 35 | 4 | 364_DN | |
| Drug | Chlorzoxazone [95-25-0]; Up 200; 23.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 2263_UP | |
| Drug | Oxybenzone [131-57-7]; Down 200; 17.6uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 6469_DN | |
| Drug | 5194442; Up 200; 20uM; PC3; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 6594_UP | |
| Drug | Protoveratrine A [143-57-7]; Up 200; 5uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 4963_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 2217_UP | |
| Drug | Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A | 2.26e-04 | 196 | 35 | 4 | 2484_UP | |
| Drug | (-)-quinpirole hydrochloride; Up 200; 1uM; MCF7; HG-U133A | 2.31e-04 | 197 | 35 | 4 | 456_UP | |
| Drug | Trichlormethiazide [133-67-5]; Up 200; 10.6uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 4198_UP | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3978_UP | |
| Drug | Captopril [62571-86-2]; Up 200; 17.2uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 4585_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 6830_UP | |
| Drug | Alfaxalone [23930-19-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 6514_UP | |
| Drug | Cinchonine [118-10-5]; Up 200; 13.6uM; PC3; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3988_UP | |
| Drug | Chloropyramine hydrochloride [6170-42-9]; Up 200; 12.2uM; HL60; HT_HG-U133A | 2.31e-04 | 197 | 35 | 4 | 3011_UP | |
| Drug | Vitexin [3681-93-4]; Up 200; 9.2uM; HL60; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 2155_UP | |
| Drug | Tridihexethyl chloride; Up 200; 11.4uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 5067_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 5680_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 3929_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 50uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4446_UP | |
| Drug | estradiol, USP; Up 200; 0.01uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 1241_UP | |
| Drug | Corticosterone [50-22-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 4145_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 2251_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; PC3; HT_HG-U133A | 2.35e-04 | 198 | 35 | 4 | 3663_UP | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 3198_UP | |
| Drug | Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 4494_UP | |
| Drug | Mephentermine hemisulfate [1212-72-2]; Up 200; 9.4uM; HL60; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 2563_UP | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 1699_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 2.40e-04 | 199 | 35 | 4 | 4595_UP | |
| Drug | tamoxifen citrate; Up 200; 1uM; ssMCF7; HG-U133A | 2.44e-04 | 200 | 35 | 4 | 375_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HT_HG-U133A | 2.44e-04 | 200 | 35 | 4 | 5570_UP | |
| Disease | heart septal defect | 1.81e-05 | 6 | 33 | 2 | MONDO_0002078 | |
| Disease | platelet component distribution width | 1.69e-04 | 755 | 33 | 6 | EFO_0007984 | |
| Disease | Tachycardia | 1.84e-04 | 18 | 33 | 2 | C0039231 | |
| Disease | Tachyarrhythmia | 1.84e-04 | 18 | 33 | 2 | C0080203 | |
| Disease | West Syndrome | 3.30e-04 | 24 | 33 | 2 | C0037769 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VQVHYRMCQSCVELD | 86 | P04234 | |
| RNEVKCRCNYTSVVM | 371 | Q8IZF3 | |
| CETRYIVENCNCRMV | 311 | Q16515 | |
| HYATIMNQRLCCILV | 131 | A0A0X1KG70 | |
| EGRHYCRENTMCVNT | 446 | Q99435 | |
| HEVMRDECYCQVVKQ | 3106 | Q9UKN7 | |
| HYATIMNRRLCCILV | 131 | Q8NGD0 | |
| HYATIMNQRLCCILV | 131 | Q8NGB6 | |
| YSDRIQVLRNMVHCA | 576 | P27815 | |
| VRMSETCVQVHRCQT | 101 | P55259 | |
| REVQCLICCLLHQMY | 991 | Q9H0H0 | |
| YCQHLVDQCRHRLLM | 686 | Q9HAQ2 | |
| HYMQVLVCQHECVRE | 276 | Q8IVL5 | |
| EDLSRSQVRCYVHIM | 291 | Q9NR50 | |
| RQVMCVNYSDHVIDR | 1261 | Q9P2N4 | |
| MVHYCENITECRRIQ | 1026 | P54132 | |
| RQVCEQLIQSHMARY | 1621 | Q05707 | |
| EQLRYCQHVLCETVR | 321 | Q6UW02 | |
| QYLCDCQVRHRIEAI | 1911 | Q92736 | |
| ICAEMYQVSRLQHIC | 496 | O94955 | |
| ERRCQICQHLCYLSM | 1136 | Q92833 | |
| HYVTVMNRRCCVLLL | 131 | Q8NH93 | |
| YEVRSCMCRQLENIA | 226 | Q6NUP7 | |
| LQRTRDYHDCMNVVE | 4236 | Q8NF91 | |
| LVYRRHCEATVDVVM | 371 | P48378 | |
| VEMIRQHLCQYTQLR | 416 | O60861 | |
| DCRDIIQRMHLRQYE | 1021 | Q5JWF2 | |
| NHARLMVVEERCVYC | 101 | Q9Y255 | |
| YTCRTRTHNICMVSD | 26 | P37287 | |
| CTQQHREDYQLVMVC | 1916 | Q63HN8 | |
| ERIHMREKPYECQQC | 551 | Q96GE5 | |
| VTRCYEVVMNVVHQL | 151 | Q2M389 | |
| YKRQVNECEAIMEHC | 1786 | Q9BXT5 | |
| YMDRKEARVCVICHS | 741 | O95405 | |
| REMVYCLEQGLIHRC | 786 | P49815 | |
| LMQHILRCDYEACRQ | 876 | O95071 |